Product Information
DOXEPIN 150 MG CAPSULE is a generic product labeled by Endo USA Inc., priced at $0.4964 per EA under NDC 49884022201. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
150 mg/1
Manufacturer
Endo USA Inc.NDC
49884022201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA071422On Market Since
11/9/1987
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 150 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 18.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4964 per EA |
|---|---|
| All-time high | $0.8872 (Sep 14, 2016) |
| All-time low | $0.3152 (Jul 17, 2024) |
| 52-week high | $0.5631 |
| 52-week low | $0.4907 |
| Median price | $0.6857 |
| Average price | $0.6672 |
| Largest weekly change | +48.3% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DOXEPIN 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 150 MG CAPSULE, manufactured by Endo USA Inc., is $0.4964 per EA (NDC 49884022201), effective Jun 24, 2026.
How has the price of DOXEPIN 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 150 MG CAPSULE has risen 18.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DOXEPIN 150 MG CAPSULE?
Since Nov 28, 2013, the NADAC for DOXEPIN 150 MG CAPSULE has ranged from a low of $0.3152 (Jul 17, 2024) to a high of $0.8872 (Sep 14, 2016), with a median of $0.6857 per EA.
Are there cheaper alternatives to DOXEPIN 150 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DOXEPIN 150 MG CAPSULE, but none are currently priced below it.
Who manufactures DOXEPIN 150 MG CAPSULE?
DOXEPIN 150 MG CAPSULE (NDC 49884022201) is labeled by Endo USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification